Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple ...

Rather than yeast or microalgae, the company is working with oleaginous bacteria—which it claims are more productive.

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

An announcement from Daré Bioscience ( ($DARE) ) is now available. On January 6, 2026, Daré Bioscience, Inc. made an updated corporate ...

Skye Bioscience Inc. (NASDAQ:SKYE) shares gained 5.3% in premarket trading on Monday after the company revealed a ...

A new Special Report published in the journal BioScience warns that long-term ecological and evolutionary research faces ...

After striking out in the pandemic phase of COVID-19 with its belated vaccine, Novavax seeks to recover in the endemic phase. And a big part of the company's plan centers around enhancing its ...

Bioscience Los Angeles County Inc. — a catalyst for life sciences in Greater Los Angeles — has launched its new growth phase under the leadership of recently appointed interim chief executive officer ...

Until recently, most commercial cannabis growers relied on clones, but a seed-based production revolution is on the horizon. Phylos Bioscience seeds provide exceptional uniformity with desired ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.